Rafestin-Oblin Marie-Edith, Fagart Jerome, Souque Anny, Seguin Cendrine, Bens Marcelle, Vandewalle Alain
Institut National de la Santé et de la Recherche Médicale U478, Institut Fédératif de Recherche 02, Faculté de Médecine Xavier Bichat, Paris, France.
Mol Pharmacol. 2002 Dec;62(6):1306-13. doi: 10.1124/mol.62.6.1306.
The binding of mineralocorticoid hormones to the mineralocorticoid receptor is the first step in a cascade of events leading to the stimulation of Na(+) reabsorption by renal cortical collecting duct (CCD) principal cells. The agonist properties of mineralocorticoid hormones are linked to contacts between their 21-hydroxyl group and Asn770, a residue of the ligand-binding domain of the human mineralocorticoid receptor (hMR). Here, we investigate whether the presence of a hydroxyl group at position 11, 17, or 20 could also alter the activity of progesterone (P), a mineralocorticoid antagonist without the 21-hydroxyl group. Both 17 alpha-hydroxyprogesterone (17OHP) and 20 alpha-hydroxyprogesterone (20OHP) antagonized the aldosterone-induced trans-activation activity (IC(50): 17OHP, 10(-7) M; 20OHP, 10(-8) M) of the hMR transiently expressed in COS-7 cells lacking steroid receptors. In cultured mouse mpkCCD(cl4) principal cells, 17OHP and 20OHP also prevented the aldosterone-stimulated amiloride-sensitive component of the short-circuit current (Ams I(sc)), reflecting Na(+) absorption mediated by the epithelial Na(+) channel (ENaC). In contrast, 11 beta-hydroxyprogesterone (11OHP) activated the transiently expressed hMR in COS-7 cells in a dose-dependent manner (ED(50): 10(-8) M) and, like aldosterone, stimulated Ams I(sc) in mpkCCD(cl4) cells. Docking 11OHP within the hMR-ligand-binding domain homology model revealed that the agonist activity of 11OHP is caused by contacts between its 11 beta-hydroxyl group and Asn770. Furthermore, 11OHP was unable to activate the mutant hMR/N770A, in which Ala is substituted for Asn at position 770. These findings demonstrate that in the absence of the 21-hydroxyl group, the 11 beta-hydroxyl group can produce the contact with the hMR-Asn770 required for the hMR activation leading to stimulated Na(+) absorption.
盐皮质激素与盐皮质激素受体的结合是一系列导致肾皮质集合管(CCD)主细胞钠(Na⁺)重吸收受刺激的事件的第一步。盐皮质激素的激动剂特性与其21-羟基与天冬酰胺770(人盐皮质激素受体(hMR)配体结合域的一个残基)之间的接触有关。在此,我们研究11、17或20位存在羟基是否也会改变孕酮(P)的活性,孕酮是一种没有21-羟基的盐皮质激素拮抗剂。17α-羟基孕酮(17OHP)和20α-羟基孕酮(20OHP)均拮抗醛固酮诱导的在缺乏类固醇受体的COS-7细胞中瞬时表达的hMR的反式激活活性(IC₅₀:17OHP,10⁻⁷M;20OHP,10⁻⁸M)。在培养的小鼠mpkCCD(cl4)主细胞中,17OHP和20OHP还阻止了醛固酮刺激的短路电流(Ams I(sc))的氨氯地平敏感成分,这反映了由上皮钠(Na⁺)通道(ENaC)介导的Na⁺吸收。相反,11β-羟基孕酮(11OHP)以剂量依赖方式激活COS-7细胞中瞬时表达的hMR(ED₅₀:10⁻⁸M),并且与醛固酮一样,刺激mpkCCD(cl4)细胞中的Ams I(sc)。将11OHP对接至hMR配体结合域同源模型显示,11OHP的激动剂活性是由其11β-羟基与天冬酰胺770之间的接触引起的。此外,11OHP无法激活突变型hMR/N770A,其中在770位天冬酰胺被丙氨酸取代。这些发现表明,在没有21-羟基的情况下,11β-羟基可与hMR-天冬酰胺770产生hMR激活所需的接触,从而导致Na⁺吸收受刺激。